Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Aug 9;12(16):1591. doi: 10.3390/healthcare12161591

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Impact of patients’ influenza or influenza-like illness (ILI) on work productivity of caregivers in Europe. (A) Impact of patient’s disease severity [21,27,41]. (B) Impact of patient’s vaccination status/treatment usage [50,52]. IIV, inactivated influenza vaccine; LAIV, live attenuated influenza vaccine; Plbo, placebo. (C) Impact of patients’ influenza status (positive or negative) [24,39]. (D) Impact of patients’ influenza viral type (influenza A or B) [26,27,39,40,51]. Note—The total cohort (N) represents the number of patients with influenza or ILI examined in the respective study sub-cohort. For example, Galante 2012 in (A) included a total of 396 patients with ILI, with 172 and 224 in the sub-cohorts of inpatients and outpatients, respectively. The total cohort (N) also serves as a proxy if the number of caregivers was not explicitly reported in that study sub-cohort.

Impact of patients’ influenza or influenza-like illness (ILI) on work productivity of caregivers in Europe. (A) Impact of patient’s disease severity [21,27,41]. (B) Impact of patient’s vaccination status/treatment usage [50,52]. IIV, inactivated influenza vaccine; LAIV, live attenuated influenza vaccine; Plbo, placebo. (C) Impact of patients’ influenza status (positive or negative) [24,39]. (D) Impact of patients’ influenza viral type (influenza A or B) [26,27,39,40,51]. Note—The total cohort (N) represents the number of patients with influenza or ILI examined in the respective study sub-cohort. For example, Galante 2012 in (A) included a total of 396 patients with ILI, with 172 and 224 in the sub-cohorts of inpatients and outpatients, respectively. The total cohort (N) also serves as a proxy if the number of caregivers was not explicitly reported in that study sub-cohort.